Drug Stock Tanks After Ebola Patient Treated With Its Drug Dies
Oct 8, 2014, 20:50 IST
Shares of Chimerix dropped sharply, falling as much as 5% on Wednesday, after Thomas Eric Duncan, an Ebola patient who was being treated with the company's experimental treatment, passed away.
Advertisement
More to come ...